Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | FPR1 | P21462 | 3/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7095099 | 0.89 | CFD (0.54) | CFDMAPTTDP1LMNAGAA | |
| SCHEMBL7578265 | 0.85 | ALOX5 (0.48) | ALOX5PPARGPPARAPPARD | |
| SCHEMBL28898703 | 0.80 | KDM4E (0.51) | MAPTLMNAGAABACE1ALOX5 | |
| SCHEMBL27318392 | 0.79 | CFD (0.61) | CFDMAPTTDP1LMNAGAA | |
| SCHEMBL4032384 | 0.79 | PTGS2 (0.54) | TDP1HPGDPPARGPPARAFPR1 | |
| SCHEMBL9165101 | 0.79 | TSHR (0.63) | CFDLMNAGAAPPARGPPARA | |
| SCHEMBL6696944 | 0.78 | LMNA (0.47) | CFDLMNAGAAPPARGPPARA | |
| SCHEMBL27427403 | 0.78 | PPARG (0.43) | MAPTTDP1GAAHPGDALOX5 | |
| SCHEMBL27510448 | 0.77 | HSD17B1 (0.59) | MAPTHPGD | |
| SCHEMBL10429619 | 0.76 | BACE1 (0.61) | CFDMAPTTDP1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970059-B1 | DISUBSTITUTED BIPHENYLOXAZOLINES | BAYER CROPSCIENCE AG (DE) | 2003-08-20 | — | — | EP | disclosed |
| US-20020086892-A1 | For controlling animal pests, in particular: insects, arachnids and nematodes | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-04 | — | — | US | disclosed |
| US-6410581-B1 | INSECTICIDES, MITICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
| EP-0970059-A1 | DISUBSTITUTED BIPHENYLOXAZOLINES | BAYER AG (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998039310-A1 | DISUBSTITUTED BIPHENYLOXAZOLINES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086892-A1 | For controlling animal pests, in particular: insects, arachnids and nematodes | ATXN2, HAX1, ANTXR2 | CFD 2643/4885MAPT 4396/4885TDP1 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.